Jeffrey A. Hubbell

Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland.

Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA.

ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland.